Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Nasopharyngeal carcinoma mainly occurs in the nasopharynx and is a common malignant tumor of the head and neck. The incidence of this disease is higher in Asian regions, especially in southern China and some Southeast Asian countries. Its pathogenesis is closely related to genetic factors, environmental exposure, and EB virus infection. Due to the concealed location of the nasopharynx, early manifestations of the tumor are not obvious and are easily overlooked. Patients are often diagnosed only when the disease has progressed to the middle or advanced stage.
The global distribution of nasopharyngeal carcinoma shows significant regional characteristics. The incidence is highest in South China and Southeast Asia, such as Guangdong, Guangxi, and parts of Vietnam. In contrast, the incidence in developed countries such as Europe and the United States is relatively low. In recent years, with changes in lifestyle and environmental factors, the incidence trends in some regions have fluctuated, but overall, nasopharyngeal carcinoma remains an important public health issue in East Asia and Southeast Asia.
In 2020, there were more than 133,000 new cases of nasopharyngeal carcinoma and 80,000 deaths from it worldwide. The incidence varies significantly by region: rare in the United States and Western Europe, with an incidence of 0.5–2 cases per 100,000; more common in southern China (including Hong Kong), with an incidence possibly reaching 25 cases per 100,000 annually; moderate-risk areas include Southeast Asia, North Africa and the Middle East, as well as the Arctic region. Populations migrating from high-risk to low-risk areas still carry a higher risk, but it usually decreases after several generations.
Gender and Age Distribution — The incidence in men is 2–3 times higher than in women. In high-risk populations, the peak incidence occurs at 50–59 years of age, after which it decreases.
1. Strong concealment, easy to delay diagnosis
In the early stages, nasopharyngeal carcinoma often has no obvious symptoms, and patients tend to ignore mild discomfort, allowing the tumor to progress unnoticed and missing the best opportunity for early treatment.
2. Local invasion and lymph node metastasis
The tumor easily invades adjacent tissues such as the eustachian tube and cervical lymph nodes, leading to tinnitus, hearing loss, and neck masses. In severe cases, it can affect facial nerve function, causing numbness or paralysis.
3. Significant decline in quality of life
Advanced nasopharyngeal carcinoma is often accompanied by symptoms such as epistaxis, headache, and difficulty swallowing, which cause great inconvenience in daily life and increase psychological stress.
4. High risk of recurrence and metastasis
Even after treatment, nasopharyngeal carcinoma still carries a certain recurrence rate and risk of distant metastasis, increasing treatment difficulty and patient burden.
Immune reconstruction cell therapy activates the patient’s own immune system to effectively identify and destroy cancer cells, enhancing treatment outcomes. This therapy boosts immune defense, reduces recurrence, has low side effects, and shows significant efficacy when combined with radiotherapy and chemotherapy, gradually becoming an important treatment option for nasopharyngeal carcinoma.
In actual treatment, patients often face problems such as immune function impairment, increased risk of infection, and slow recovery during traditional therapies like surgery, radiotherapy, and chemotherapy. To better support patients through treatment and improve tolerance and quality of life, it is necessary to scientifically formulate phased immune reconstruction plans for different treatment cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to strengthen the effect of anti-tumor therapy.
● Mid-term plan: Reduce the side effects of traditional treatment, promote physical recovery, and complete standardized treatment courses.
● Long-term plan: Improve overall immunity through immune cell reconstruction, intestinal immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby improving quality of life and prolonging survival.
1. Radiotherapy
As the fundamental treatment method for nasopharyngeal carcinoma, radiotherapy kills tumor cells through high-energy rays. Modern technologies such as intensity-modulated radiotherapy allow precise dose control while protecting normal tissues, making it highly effective for early and intermediate-stage patients.
2. Chemotherapy
Often combined with radiotherapy, chemotherapy controls local tumors and metastases, relieves symptoms, and improves prognosis. A variety of chemotherapy drugs are available and can be individualized according to the patient’s condition.
3. Surgical treatment
Surgery is mainly used for localized or recurrent lesions and usually serves as an adjunctive treatment. When combined with radiotherapy and chemotherapy, it can improve surgical success rates and patient survival.
4. Minimally invasive treatment methods
In recent years, minimally invasive techniques such as endoscopic surgery and targeted drugs have been gradually applied in the treatment of nasopharyngeal carcinoma. These methods cause less trauma, allow faster recovery, and are suitable for some early-stage patients as well as postoperative adjuvant therapy.
Nasopharyngeal carcinoma is highly harmful due to its hidden onset and rapid progression. Timely diagnosis and scientific treatment are crucial for improving survival rates. Experts from the United Life International Medical Center point out that immune reconstruction cell therapy, as an emerging treatment, has the potential to improve outcomes and quality of life. It is recommended that patients seek medical attention early and actively cooperate with multidisciplinary comprehensive treatment.
